Deal overview

Deal overview
Target QIAGEN NV
Bidder THERMO FISHER SCIENTIFIC INC
Price £0.00 Full version or £25.00 Light version
Publication Date Mar 03, 2020
Abstract On 3 March 2020, the quoted US-based life sciences company Thermo Fisher Scientific Inc ("Thermo Fisher") announced a recommended cash offer for QIAGEN NV ("QIAGEN"), a Dutch diagnostics company listed in Frankfurt and New York. The offer of €39 per share valued 100% of QIAGEN's equity at approximately €9.2 billion. The transaction, which was expected to be completed in ...
Number of pages (Full version) 0
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.024865s